New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Surrozen, Inc.

Contributing Author

Recent Articles by Surrozen, Inc.

Mar-23	Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update SRZN GlobeNewswire
Feb-25	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN GlobeNewswire
Feb-23	Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SRZN GlobeNewswire
Feb-05	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN -10.15% SRZN +7.29% GlobeNewswire
Nov-25	Surrozen to Present at Upcoming Healthcare Investor Conferences SRZN +22.21% GlobeNewswire
Nov-12	Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SRZN +6.80% SRZN -6.34% GlobeNewswire
Nov-07	Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update SRZN GlobeNewswire
Nov-05	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN GlobeNewswire
Sep-04	Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SRZN GlobeNewswire
Sep-03	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN GlobeNewswire
Aug-28	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN GlobeNewswire
Aug-08	Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update SRZN +5.87% GlobeNewswire
Aug-06	Surrozen to Present at Upcoming Healthcare Investor Conference SRZN -12.83% SRZN GlobeNewswire
May-14	Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway SRZN -9.72% GlobeNewswire
May-09	Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update SRZN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)